From the biological perspective, this finding also supports the notion that NF-κB activation and related changes in gene expression may be the key factor determining the biological differences previously reported for TRAF3/CYLD mutant HPV+ HNSCC. The gene discussed is NFKB1; the disease is head and neck squamous cell carcinoma.